IPP
Actin-binding protein IPP
Also known as: IPP_HUMAN, KLHL27
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9Y573
- Gene
- IPP
- Ensembl
- ENSG00000197429
- Chromosome
- 1
- Canonical length
- 584 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins
OverviewNCBI Gene
The protein encoded by this gene is a member of the kelch family of proteins, which is characterized by a 50 amino acid repeat which interacts with actin. Transcript variants have been described but their full-length nature has not been determined. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
584 residues, UniProt reviewed canonical sequence.
>Q9Y573|IPP
1 MANEDCPKAA DSPFSSDKHA QLILAQINKM RNGQHFCDVQ LQVGQESFKA HRLVLAASSP
61 YFAALFTGGM KESSKDVVPI LGIEAGIFQI LLDFIYTGIV NIGVNNVQEL IIAADMLQLT
121 EVVHLCCEFL KGQIDPLNCI GIFQFSEQIA CHDLLEFSEN YIHVHFLEVH SGEEFLALTK
181 DQLIKILRSE ELSIEDEYQV FLAAMQWILK DLGKRRKHVV EVLDPIRFPL LPPQRLLKYI
241 EGVSDFNLRV ALQTLLKEYC EVCKSPKENK FCSFLQTSKV RPRKKARKYL YAVGGYTRLQ
301 GGRWSDSRAL SCVERFDTFS QYWTTVSSLH QARSGLGVTV LGGMVYAIGG EKDSMIFDCT
361 ECYDPVTKQW TTVASMNHPR CGLGVCVCYG AIYALGGWVG AEIGNTIERF DPDENKWEVV
421 GNMAVSRYYF GCCEMQGLIY VIGGISNEGI ELRSFEVYDP LSKRWSPLPP MGTRRAYLGV
481 AALNDCIYSV GGWNETQDAL HTVEKYSFEE EKWVEVASMK VPRAGMCVVA VNGLLYVSGG
541 RSSSHDFLAP GTLDSVEVYN PHSDTWTEIG NMITSRCEGG VAVLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IPP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 13 nTPM
- testis: 9.5 nTPM
- thyroid gland: 9.1 nTPM
- parathyroid gland: 8.9 nTPM
- tongue: 8.4 nTPM
- retina: 6.8 nTPM
Single-cell type
- myonuclei: 53 nCPM
- late primary spermatocytes: 53 nCPM
- podocytes: 49 nCPM
- neutrophils: 47 nCPM
- early primary spermatocytes: 46 nCPM
- renal connecting tubule cells: 42 nCPM
Immune cell
- T-reg: 4.7 nTPM
- gdT-cell: 4.6 nTPM
- basophil: 4.1 nTPM
- naive CD8 T-cell: 4 nTPM
- NK-cell: 3.8 nTPM
- memory CD8 T-cell: 3.7 nTPM
Brain region
- white matter: 14 nTPM
- basal ganglia: 13 nTPM
- hypothalamus: 13 nTPM
- cerebellum: 12 nTPM
- midbrain: 12 nTPM
- medulla oblongata: 12 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.69
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.5
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- BTB/POZ domain
- Kelch repeat type 1
- Galactose oxidase/kelch, beta-propeller
- SKP1/BTB/POZ domain superfamily
- BTB/Kelch-associated
- Kelch-type beta-propeller
- BTB-kelch protein
- BTB/POZ domain
- Kelch motif
- BTB And C-terminal Kelch
- KLHDC2/KLHL20/DRC7 Kelch-repeats domain
- Actin-binding protein IPP, BTB/POZ domain
- Actin-binding protein IPP, BACK domain
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IPP as an antibody target. Whether an autoantibody or antibody against IPP could matter depends on whether native IPP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IPP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label IPP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...